MedPath

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery

Phase 3
Completed
Conditions
Postoperative Emesis
Postoperative Vomiting
Postoperative Nausea
Interventions
Registration Number
NCT02744495
Lead Sponsor
Hôpital Privé de Parly II - Le Chesnay
Brief Summary

To investigate the role of postoperative nausea and vomiting risk factors assessment after cardiac surgery. We designed a randomized controlled study comparing standard care (no risk factor assessment and no intervention) with prophylaxis of postoperative nausea and vomiting after cardiac surgery in high risk patients. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors (if risk score is over 2) in the intervention arm.

Detailed Description

Patients planned to undergo cardiac surgery were screened for inclusion. Inclusion criteria are as follow: Non emergent cardiac surgery; Age \> 18 years; Affiliation to French Social Security; Approval of participation to the study; at the exclusion of: Pregnancy ; Contra indication to antiemetics; Chronic usage of antiemetics; and Emergent or complicated surgery.

Risk factors for postoperative nausea and vomiting were collected and patients were randomized by cluster into two arms.

Control: No prophylaxis whatever risk score is. Postoperative nausea and vomiting risk factors were not available for practicians.

Intervention: Preoperative collection of postoperative nausea and vomiting risk factors available for practicians. Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

All outcomes are assessed at 48 hours of surgery:

Primary: occurrence of postoperative nausea or vomiting Secondary: number of postoperative nausea and vomiting with visual assessment scale (VAS), and antiemetics used for treatment; postoperative pain (VAS) with number of analgesics used; postoperative discomfort (VAS).

Safety data: side effects and QT corrected intervals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
502
Inclusion Criteria
  • Non emergent cardiac surgery
  • Age > 18 years
  • Affiliation to French Social Security
  • Approval of participation to the study
Exclusion Criteria
  • Pregnancy
  • Contra indication to antiemetics
  • Chronic usage of antiemetics
  • Emergent or complicated surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
postoperative nausea and vomiting risk factorsBetamethasonePreoperative collection of postoperative nausea and vomiting risk factors available for practicians.
postoperative nausea and vomiting risk factorsDroperidolPreoperative collection of postoperative nausea and vomiting risk factors available for practicians.
Primary Outcome Measures
NameTimeMethod
postoperative nausea and vomiting48hour

postoperative nausea and vomiting as a categorical variable

Secondary Outcome Measures
NameTimeMethod
Side effects48hour
number of postoperative nausea and vomiting48hour
postoperative nausea and vomiting (VAS)48hour

Suffering from postoperative nausea and vomiting by visual assessment scale (VAS). VAS is a 100 point scale: 0 indicate absence of nausea or vomiting; 100 indicate maximal nausea and vomiting

postoperative pain (VAS)48hour

VAS is a 100 point scale: 0 indicate absence of pain; 100 indicate maximal pain

postoperative discomfort (VAS)48hour

VAS is a 100 point scale: 0 indicate absence of discomfort; 100 indicate maximal discomfort

Antiemetics (treatment)48hour

Number of antiemetics used as a treatment for postoperative nausea or vomiting

Analgesics48hour

Number of Analgesics used at 48h

QTc interval48hour

Pre and postoperative QTc (corrected) intervals

Trial Locations

Locations (1)

Parly2

🇫🇷

Le Chesnay, France

© Copyright 2025. All Rights Reserved by MedPath